nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticlopidine—CYP1A2—Imiquimod—skin cancer	0.0961	0.112	CbGbCtD
Ticlopidine—CYP1A1—Dacarbazine—skin cancer	0.0903	0.105	CbGbCtD
Ticlopidine—CYP2C8—Vismodegib—skin cancer	0.086	0.1	CbGbCtD
Ticlopidine—CYP2C19—Vismodegib—skin cancer	0.0722	0.084	CbGbCtD
Ticlopidine—CYP2E1—Dacarbazine—skin cancer	0.0698	0.0812	CbGbCtD
Ticlopidine—CYP2C9—Vismodegib—skin cancer	0.06	0.0699	CbGbCtD
Ticlopidine—CYP1A2—Vemurafenib—skin cancer	0.0526	0.0613	CbGbCtD
Ticlopidine—CYP3A4—Imiquimod—skin cancer	0.0503	0.0586	CbGbCtD
Ticlopidine—CYP3A4—Temozolomide—skin cancer	0.0503	0.0586	CbGbCtD
Ticlopidine—CYP2D6—Vemurafenib—skin cancer	0.0434	0.0505	CbGbCtD
Ticlopidine—CYP1A2—Dacarbazine—skin cancer	0.0403	0.047	CbGbCtD
Ticlopidine—CYP3A4—Vismodegib—skin cancer	0.0349	0.0406	CbGbCtD
Ticlopidine—CYP2C8—Fluorouracil—skin cancer	0.0306	0.0356	CbGbCtD
Ticlopidine—CYP3A4—Vemurafenib—skin cancer	0.0276	0.0321	CbGbCtD
Ticlopidine—CYP1A2—Fluorouracil—skin cancer	0.0236	0.0275	CbGbCtD
Ticlopidine—CYP2C9—Fluorouracil—skin cancer	0.0213	0.0248	CbGbCtD
Ticlopidine—CYP3A4—Docetaxel—skin cancer	0.00946	0.011	CbGbCtD
Ticlopidine—Diarrhoea haemorrhagic—Docetaxel—skin cancer	0.00316	0.024	CcSEcCtD
Ticlopidine—Hyponatraemia—Vismodegib—skin cancer	0.00277	0.0211	CcSEcCtD
Ticlopidine—Vasculitis—Vemurafenib—skin cancer	0.00241	0.0183	CcSEcCtD
Ticlopidine—Lupus erythematosus—Docetaxel—skin cancer	0.00214	0.0163	CcSEcCtD
Ticlopidine—Lung disorder—Temozolomide—skin cancer	0.0017	0.0129	CcSEcCtD
Ticlopidine—Muscle spasms—Vismodegib—skin cancer	0.0016	0.0121	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Imiquimod—skin cancer	0.00154	0.0117	CcSEcCtD
Ticlopidine—Purpura—Imiquimod—skin cancer	0.00151	0.0115	CcSEcCtD
Ticlopidine—Eosinophilia—Vemurafenib—skin cancer	0.00146	0.0111	CcSEcCtD
Ticlopidine—Systemic lupus erythematosus—Docetaxel—skin cancer	0.00144	0.011	CcSEcCtD
Ticlopidine—Arthralgia—Vismodegib—skin cancer	0.00141	0.0108	CcSEcCtD
Ticlopidine—Myalgia—Vismodegib—skin cancer	0.00141	0.0108	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.0013	0.0099	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Vemurafenib—skin cancer	0.00129	0.00979	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00124	0.00939	CcSEcCtD
Ticlopidine—Dyspepsia—Vismodegib—skin cancer	0.00119	0.00907	CcSEcCtD
Ticlopidine—Pancytopenia—Imiquimod—skin cancer	0.00119	0.00907	CcSEcCtD
Ticlopidine—Decreased appetite—Vismodegib—skin cancer	0.00118	0.00896	CcSEcCtD
Ticlopidine—Pain—Vismodegib—skin cancer	0.00116	0.00881	CcSEcCtD
Ticlopidine—Sepsis—Dactinomycin—skin cancer	0.00115	0.00875	CcSEcCtD
Ticlopidine—Erythema multiforme—Vemurafenib—skin cancer	0.00111	0.00847	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00111	0.00844	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Vismodegib—skin cancer	0.00111	0.00843	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Imiquimod—skin cancer	0.0011	0.00835	CcSEcCtD
Ticlopidine—Hepatic failure—Dactinomycin—skin cancer	0.00107	0.00815	CcSEcCtD
Ticlopidine—Haemoglobin—Imiquimod—skin cancer	0.00101	0.00768	CcSEcCtD
Ticlopidine—Haemorrhage—Imiquimod—skin cancer	0.00101	0.00764	CcSEcCtD
Ticlopidine—Vascular purpura—Temozolomide—skin cancer	0.000974	0.0074	CcSEcCtD
Ticlopidine—Asthenia—Vismodegib—skin cancer	0.000973	0.0074	CcSEcCtD
Ticlopidine—P2RY12—epithelium—skin cancer	0.00097	0.0996	CbGeAlD
Ticlopidine—Hepatic failure—Temozolomide—skin cancer	0.000969	0.00737	CcSEcCtD
Ticlopidine—Sepsis—Fluorouracil—skin cancer	0.00096	0.00729	CcSEcCtD
Ticlopidine—Pruritus—Vismodegib—skin cancer	0.000959	0.00729	CcSEcCtD
Ticlopidine—Erythema multiforme—Imiquimod—skin cancer	0.000951	0.00723	CcSEcCtD
Ticlopidine—MPO—endothelium—skin cancer	0.000948	0.0973	CbGeAlD
Ticlopidine—Tinnitus—Imiquimod—skin cancer	0.000938	0.00713	CcSEcCtD
Ticlopidine—Diarrhoea—Vismodegib—skin cancer	0.000928	0.00705	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Temozolomide—skin cancer	0.000923	0.00702	CcSEcCtD
Ticlopidine—Purpura—Temozolomide—skin cancer	0.000904	0.00687	CcSEcCtD
Ticlopidine—Liver function test abnormal—Dactinomycin—skin cancer	0.000889	0.00676	CcSEcCtD
Ticlopidine—MPO—blood vessel—skin cancer	0.000874	0.0898	CbGeAlD
Ticlopidine—Myalgia—Vemurafenib—skin cancer	0.000874	0.00664	CcSEcCtD
Ticlopidine—Arthralgia—Vemurafenib—skin cancer	0.000874	0.00664	CcSEcCtD
Ticlopidine—Vomiting—Vismodegib—skin cancer	0.000862	0.00655	CcSEcCtD
Ticlopidine—Rash—Vismodegib—skin cancer	0.000855	0.0065	CcSEcCtD
Ticlopidine—Dermatitis—Vismodegib—skin cancer	0.000854	0.00649	CcSEcCtD
Ticlopidine—Pancytopenia—Bleomycin—skin cancer	0.000848	0.00644	CcSEcCtD
Ticlopidine—Anaphylactic shock—Vemurafenib—skin cancer	0.000838	0.00637	CcSEcCtD
Ticlopidine—Nausea—Vismodegib—skin cancer	0.000806	0.00612	CcSEcCtD
Ticlopidine—Osteoarthritis—Fluorouracil—skin cancer	0.000803	0.0061	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Fluorouracil—skin cancer	0.000803	0.0061	CcSEcCtD
Ticlopidine—Angioedema—Imiquimod—skin cancer	0.0008	0.00608	CcSEcCtD
Ticlopidine—Pancytopenia—Dactinomycin—skin cancer	0.000791	0.00601	CcSEcCtD
Ticlopidine—Colitis—Docetaxel—skin cancer	0.000766	0.00582	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.000763	0.0058	CcSEcCtD
Ticlopidine—Haematuria—Bleomycin—skin cancer	0.000759	0.00577	CcSEcCtD
Ticlopidine—Abdominal distension—Temozolomide—skin cancer	0.000758	0.00576	CcSEcCtD
Ticlopidine—Arthralgia—Imiquimod—skin cancer	0.000745	0.00567	CcSEcCtD
Ticlopidine—Myalgia—Imiquimod—skin cancer	0.000745	0.00567	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.000736	0.00559	CcSEcCtD
Ticlopidine—Decreased appetite—Vemurafenib—skin cancer	0.000728	0.00554	CcSEcCtD
Ticlopidine—Haemoglobin—Bleomycin—skin cancer	0.000718	0.00546	CcSEcCtD
Ticlopidine—Pancytopenia—Temozolomide—skin cancer	0.000715	0.00543	CcSEcCtD
Ticlopidine—Haemorrhage—Bleomycin—skin cancer	0.000714	0.00543	CcSEcCtD
Ticlopidine—CYP1A1—skin epidermis—skin cancer	0.000706	0.0724	CbGeAlD
Ticlopidine—Sepsis—Docetaxel—skin cancer	0.000693	0.00526	CcSEcCtD
Ticlopidine—Eosinophilia—Fluorouracil—skin cancer	0.000687	0.00522	CcSEcCtD
Ticlopidine—Anorexia—Imiquimod—skin cancer	0.000681	0.00518	CcSEcCtD
Ticlopidine—Hepatitis—Dactinomycin—skin cancer	0.000666	0.00506	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000666	0.00506	CcSEcCtD
Ticlopidine—Body temperature increased—Vemurafenib—skin cancer	0.000662	0.00503	CcSEcCtD
Ticlopidine—Pancytopenia—Fluorouracil—skin cancer	0.000659	0.00501	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Temozolomide—skin cancer	0.000658	0.005	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000651	0.00495	CcSEcCtD
Ticlopidine—Hepatic failure—Docetaxel—skin cancer	0.000645	0.0049	CcSEcCtD
Ticlopidine—Erythema multiforme—Dactinomycin—skin cancer	0.00063	0.00479	CcSEcCtD
Ticlopidine—Dyspepsia—Imiquimod—skin cancer	0.000629	0.00478	CcSEcCtD
Ticlopidine—Decreased appetite—Imiquimod—skin cancer	0.000621	0.00472	CcSEcCtD
Ticlopidine—Hypersensitivity—Vemurafenib—skin cancer	0.000617	0.00469	CcSEcCtD
Ticlopidine—Pain—Imiquimod—skin cancer	0.000611	0.00464	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Fluorouracil—skin cancer	0.000606	0.00461	CcSEcCtD
Ticlopidine—Haemoglobin—Temozolomide—skin cancer	0.000606	0.0046	CcSEcCtD
Ticlopidine—Haemorrhage—Temozolomide—skin cancer	0.000603	0.00458	CcSEcCtD
Ticlopidine—Hepatitis—Temozolomide—skin cancer	0.000603	0.00458	CcSEcCtD
Ticlopidine—P2RY12—head—skin cancer	0.000602	0.0618	CbGeAlD
Ticlopidine—Asthenia—Vemurafenib—skin cancer	0.000601	0.00457	CcSEcCtD
Ticlopidine—Pruritus—Vemurafenib—skin cancer	0.000593	0.00451	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Imiquimod—skin cancer	0.000584	0.00444	CcSEcCtD
Ticlopidine—Epistaxis—Fluorouracil—skin cancer	0.000583	0.00443	CcSEcCtD
Ticlopidine—Hyponatraemia—Docetaxel—skin cancer	0.000582	0.00442	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000579	0.0044	CcSEcCtD
Ticlopidine—Diarrhoea—Vemurafenib—skin cancer	0.000573	0.00436	CcSEcCtD
Ticlopidine—Erythema multiforme—Temozolomide—skin cancer	0.00057	0.00433	CcSEcCtD
Ticlopidine—Urticaria—Imiquimod—skin cancer	0.000568	0.00431	CcSEcCtD
Ticlopidine—Body temperature increased—Imiquimod—skin cancer	0.000565	0.00429	CcSEcCtD
Ticlopidine—Tinnitus—Temozolomide—skin cancer	0.000562	0.00427	CcSEcCtD
Ticlopidine—Haemoglobin—Fluorouracil—skin cancer	0.000558	0.00424	CcSEcCtD
Ticlopidine—Haemorrhage—Fluorouracil—skin cancer	0.000555	0.00422	CcSEcCtD
Ticlopidine—Dizziness—Vemurafenib—skin cancer	0.000554	0.00421	CcSEcCtD
Ticlopidine—Liver function test abnormal—Docetaxel—skin cancer	0.000535	0.00407	CcSEcCtD
Ticlopidine—Vomiting—Vemurafenib—skin cancer	0.000533	0.00405	CcSEcCtD
Ticlopidine—Myalgia—Bleomycin—skin cancer	0.00053	0.00402	CcSEcCtD
Ticlopidine—Rash—Vemurafenib—skin cancer	0.000528	0.00402	CcSEcCtD
Ticlopidine—Dermatitis—Vemurafenib—skin cancer	0.000528	0.00401	CcSEcCtD
Ticlopidine—Hypersensitivity—Imiquimod—skin cancer	0.000526	0.004	CcSEcCtD
Ticlopidine—Headache—Vemurafenib—skin cancer	0.000525	0.00399	CcSEcCtD
Ticlopidine—Cramp muscle—Docetaxel—skin cancer	0.000522	0.00397	CcSEcCtD
Ticlopidine—Asthenia—Imiquimod—skin cancer	0.000513	0.0039	CcSEcCtD
Ticlopidine—Anaphylactic shock—Bleomycin—skin cancer	0.000508	0.00386	CcSEcCtD
Ticlopidine—Pruritus—Imiquimod—skin cancer	0.000506	0.00384	CcSEcCtD
Ticlopidine—Nausea—Vemurafenib—skin cancer	0.000498	0.00378	CcSEcCtD
Ticlopidine—Thrombocytopenia—Bleomycin—skin cancer	0.000497	0.00378	CcSEcCtD
Ticlopidine—Myalgia—Dactinomycin—skin cancer	0.000494	0.00375	CcSEcCtD
Ticlopidine—Diarrhoea—Imiquimod—skin cancer	0.000489	0.00372	CcSEcCtD
Ticlopidine—Anorexia—Bleomycin—skin cancer	0.000484	0.00368	CcSEcCtD
Ticlopidine—Angioedema—Temozolomide—skin cancer	0.000479	0.00364	CcSEcCtD
Ticlopidine—Pancytopenia—Docetaxel—skin cancer	0.000476	0.00361	CcSEcCtD
Ticlopidine—Dizziness—Imiquimod—skin cancer	0.000472	0.00359	CcSEcCtD
Ticlopidine—Thrombocytopenia—Dactinomycin—skin cancer	0.000464	0.00352	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000462	0.00352	CcSEcCtD
Ticlopidine—Vomiting—Imiquimod—skin cancer	0.000454	0.00345	CcSEcCtD
Ticlopidine—Anorexia—Dactinomycin—skin cancer	0.000451	0.00343	CcSEcCtD
Ticlopidine—Rash—Imiquimod—skin cancer	0.000451	0.00342	CcSEcCtD
Ticlopidine—Dermatitis—Imiquimod—skin cancer	0.00045	0.00342	CcSEcCtD
Ticlopidine—MPO—connective tissue—skin cancer	0.000448	0.046	CbGeAlD
Ticlopidine—Headache—Imiquimod—skin cancer	0.000448	0.0034	CcSEcCtD
Ticlopidine—Arthralgia—Temozolomide—skin cancer	0.000447	0.00339	CcSEcCtD
Ticlopidine—Myalgia—Temozolomide—skin cancer	0.000447	0.00339	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000443	0.00336	CcSEcCtD
Ticlopidine—Decreased appetite—Bleomycin—skin cancer	0.000441	0.00335	CcSEcCtD
Ticlopidine—Renal failure—Docetaxel—skin cancer	0.000439	0.00334	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Docetaxel—skin cancer	0.000438	0.00333	CcSEcCtD
Ticlopidine—Pain—Bleomycin—skin cancer	0.000434	0.0033	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000431	0.00328	CcSEcCtD
Ticlopidine—Anaphylactic shock—Temozolomide—skin cancer	0.000428	0.00325	CcSEcCtD
Ticlopidine—MPO—epithelium—skin cancer	0.000426	0.0437	CbGeAlD
Ticlopidine—Nausea—Imiquimod—skin cancer	0.000424	0.00323	CcSEcCtD
Ticlopidine—Epistaxis—Docetaxel—skin cancer	0.000421	0.0032	CcSEcCtD
Ticlopidine—Thrombocytopenia—Temozolomide—skin cancer	0.000419	0.00319	CcSEcCtD
Ticlopidine—Myalgia—Fluorouracil—skin cancer	0.000412	0.00313	CcSEcCtD
Ticlopidine—Decreased appetite—Dactinomycin—skin cancer	0.000412	0.00313	CcSEcCtD
Ticlopidine—Anorexia—Temozolomide—skin cancer	0.000408	0.0031	CcSEcCtD
Ticlopidine—Pain—Dactinomycin—skin cancer	0.000405	0.00308	CcSEcCtD
Ticlopidine—MPO—skin of body—skin cancer	0.000405	0.0416	CbGeAlD
Ticlopidine—Urticaria—Bleomycin—skin cancer	0.000403	0.00306	CcSEcCtD
Ticlopidine—Haemoglobin—Docetaxel—skin cancer	0.000403	0.00306	CcSEcCtD
Ticlopidine—Body temperature increased—Bleomycin—skin cancer	0.000401	0.00305	CcSEcCtD
Ticlopidine—Haemorrhage—Docetaxel—skin cancer	0.000401	0.00305	CcSEcCtD
Ticlopidine—Hepatitis—Docetaxel—skin cancer	0.000401	0.00305	CcSEcCtD
Ticlopidine—Anaphylactic shock—Fluorouracil—skin cancer	0.000395	0.003	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00039	0.00297	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000387	0.00294	CcSEcCtD
Ticlopidine—Thrombocytopenia—Fluorouracil—skin cancer	0.000386	0.00294	CcSEcCtD
Ticlopidine—Erythema multiforme—Docetaxel—skin cancer	0.000379	0.00288	CcSEcCtD
Ticlopidine—Dyspepsia—Temozolomide—skin cancer	0.000377	0.00286	CcSEcCtD
Ticlopidine—Anorexia—Fluorouracil—skin cancer	0.000376	0.00286	CcSEcCtD
Ticlopidine—Body temperature increased—Dactinomycin—skin cancer	0.000374	0.00284	CcSEcCtD
Ticlopidine—Hypersensitivity—Bleomycin—skin cancer	0.000374	0.00284	CcSEcCtD
Ticlopidine—Decreased appetite—Temozolomide—skin cancer	0.000372	0.00283	CcSEcCtD
Ticlopidine—Pain—Temozolomide—skin cancer	0.000366	0.00278	CcSEcCtD
Ticlopidine—Asthenia—Bleomycin—skin cancer	0.000364	0.00277	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000359	0.00273	CcSEcCtD
Ticlopidine—Pruritus—Bleomycin—skin cancer	0.000359	0.00273	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Temozolomide—skin cancer	0.00035	0.00266	CcSEcCtD
Ticlopidine—Hypersensitivity—Dactinomycin—skin cancer	0.000349	0.00265	CcSEcCtD
Ticlopidine—Dyspepsia—Fluorouracil—skin cancer	0.000347	0.00264	CcSEcCtD
Ticlopidine—CYP1A2—nipple—skin cancer	0.000346	0.0355	CbGeAlD
Ticlopidine—Decreased appetite—Fluorouracil—skin cancer	0.000343	0.00261	CcSEcCtD
Ticlopidine—CYP1A1—nipple—skin cancer	0.000341	0.035	CbGeAlD
Ticlopidine—Urticaria—Temozolomide—skin cancer	0.00034	0.00259	CcSEcCtD
Ticlopidine—Asthenia—Dactinomycin—skin cancer	0.00034	0.00258	CcSEcCtD
Ticlopidine—Body temperature increased—Temozolomide—skin cancer	0.000338	0.00257	CcSEcCtD
Ticlopidine—Pain—Fluorouracil—skin cancer	0.000337	0.00256	CcSEcCtD
Ticlopidine—Muscle spasms—Docetaxel—skin cancer	0.000335	0.00255	CcSEcCtD
Ticlopidine—MPO—lymphoid tissue—skin cancer	0.000328	0.0336	CbGeAlD
Ticlopidine—Diarrhoea—Dactinomycin—skin cancer	0.000324	0.00246	CcSEcCtD
Ticlopidine—Vomiting—Bleomycin—skin cancer	0.000323	0.00245	CcSEcCtD
Ticlopidine—Rash—Bleomycin—skin cancer	0.00032	0.00243	CcSEcCtD
Ticlopidine—Dermatitis—Bleomycin—skin cancer	0.00032	0.00243	CcSEcCtD
Ticlopidine—Hypersensitivity—Temozolomide—skin cancer	0.000315	0.0024	CcSEcCtD
Ticlopidine—Urticaria—Fluorouracil—skin cancer	0.000313	0.00238	CcSEcCtD
Ticlopidine—Body temperature increased—Fluorouracil—skin cancer	0.000312	0.00237	CcSEcCtD
Ticlopidine—Asthenia—Temozolomide—skin cancer	0.000307	0.00233	CcSEcCtD
Ticlopidine—Pruritus—Temozolomide—skin cancer	0.000303	0.0023	CcSEcCtD
Ticlopidine—Nausea—Bleomycin—skin cancer	0.000302	0.00229	CcSEcCtD
Ticlopidine—Vomiting—Dactinomycin—skin cancer	0.000301	0.00229	CcSEcCtD
Ticlopidine—Rash—Dactinomycin—skin cancer	0.000298	0.00227	CcSEcCtD
Ticlopidine—Myalgia—Docetaxel—skin cancer	0.000297	0.00226	CcSEcCtD
Ticlopidine—Arthralgia—Docetaxel—skin cancer	0.000297	0.00226	CcSEcCtD
Ticlopidine—Diarrhoea—Temozolomide—skin cancer	0.000293	0.00223	CcSEcCtD
Ticlopidine—Hypersensitivity—Fluorouracil—skin cancer	0.000291	0.00221	CcSEcCtD
Ticlopidine—Anaphylactic shock—Docetaxel—skin cancer	0.000285	0.00216	CcSEcCtD
Ticlopidine—Dizziness—Temozolomide—skin cancer	0.000283	0.00215	CcSEcCtD
Ticlopidine—Nausea—Dactinomycin—skin cancer	0.000281	0.00214	CcSEcCtD
Ticlopidine—Pruritus—Fluorouracil—skin cancer	0.000279	0.00212	CcSEcCtD
Ticlopidine—Thrombocytopenia—Docetaxel—skin cancer	0.000279	0.00212	CcSEcCtD
Ticlopidine—Vomiting—Temozolomide—skin cancer	0.000272	0.00207	CcSEcCtD
Ticlopidine—Anorexia—Docetaxel—skin cancer	0.000271	0.00206	CcSEcCtD
Ticlopidine—Rash—Temozolomide—skin cancer	0.00027	0.00205	CcSEcCtD
Ticlopidine—Diarrhoea—Fluorouracil—skin cancer	0.00027	0.00205	CcSEcCtD
Ticlopidine—Dermatitis—Temozolomide—skin cancer	0.00027	0.00205	CcSEcCtD
Ticlopidine—Headache—Temozolomide—skin cancer	0.000268	0.00204	CcSEcCtD
Ticlopidine—MPO—head—skin cancer	0.000264	0.0271	CbGeAlD
Ticlopidine—Dizziness—Fluorouracil—skin cancer	0.000261	0.00198	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000259	0.00197	CcSEcCtD
Ticlopidine—Nausea—Temozolomide—skin cancer	0.000254	0.00193	CcSEcCtD
Ticlopidine—Vomiting—Fluorouracil—skin cancer	0.000251	0.00191	CcSEcCtD
Ticlopidine—Dyspepsia—Docetaxel—skin cancer	0.000251	0.00191	CcSEcCtD
Ticlopidine—Rash—Fluorouracil—skin cancer	0.000249	0.00189	CcSEcCtD
Ticlopidine—Dermatitis—Fluorouracil—skin cancer	0.000249	0.00189	CcSEcCtD
Ticlopidine—Decreased appetite—Docetaxel—skin cancer	0.000248	0.00188	CcSEcCtD
Ticlopidine—Headache—Fluorouracil—skin cancer	0.000247	0.00188	CcSEcCtD
Ticlopidine—Pain—Docetaxel—skin cancer	0.000243	0.00185	CcSEcCtD
Ticlopidine—Nausea—Fluorouracil—skin cancer	0.000234	0.00178	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Docetaxel—skin cancer	0.000233	0.00177	CcSEcCtD
Ticlopidine—CYP1A1—epithelium—skin cancer	0.00023	0.0236	CbGeAlD
Ticlopidine—Body temperature increased—Docetaxel—skin cancer	0.000225	0.00171	CcSEcCtD
Ticlopidine—CYP1A1—skin of body—skin cancer	0.000219	0.0224	CbGeAlD
Ticlopidine—CYP2B6—skin of body—skin cancer	0.000212	0.0218	CbGeAlD
Ticlopidine—Hypersensitivity—Docetaxel—skin cancer	0.00021	0.00159	CcSEcCtD
Ticlopidine—Asthenia—Docetaxel—skin cancer	0.000204	0.00155	CcSEcCtD
Ticlopidine—Pruritus—Docetaxel—skin cancer	0.000201	0.00153	CcSEcCtD
Ticlopidine—CYP1A1—mammalian vulva—skin cancer	0.000199	0.0205	CbGeAlD
Ticlopidine—Diarrhoea—Docetaxel—skin cancer	0.000195	0.00148	CcSEcCtD
Ticlopidine—Dizziness—Docetaxel—skin cancer	0.000188	0.00143	CcSEcCtD
Ticlopidine—CYP2C8—female reproductive system—skin cancer	0.000185	0.019	CbGeAlD
Ticlopidine—MPO—lymph node—skin cancer	0.000185	0.019	CbGeAlD
Ticlopidine—Vomiting—Docetaxel—skin cancer	0.000181	0.00138	CcSEcCtD
Ticlopidine—Rash—Docetaxel—skin cancer	0.00018	0.00136	CcSEcCtD
Ticlopidine—Dermatitis—Docetaxel—skin cancer	0.000179	0.00136	CcSEcCtD
Ticlopidine—Headache—Docetaxel—skin cancer	0.000178	0.00136	CcSEcCtD
Ticlopidine—CYP2B6—lymphoid tissue—skin cancer	0.000172	0.0177	CbGeAlD
Ticlopidine—CYP1A1—female reproductive system—skin cancer	0.000171	0.0175	CbGeAlD
Ticlopidine—Nausea—Docetaxel—skin cancer	0.000169	0.00129	CcSEcCtD
Ticlopidine—CYP2B6—female reproductive system—skin cancer	0.000166	0.017	CbGeAlD
Ticlopidine—CYP2C9—female reproductive system—skin cancer	0.000164	0.0169	CbGeAlD
Ticlopidine—CYP2E1—lymphoid tissue—skin cancer	0.000161	0.0166	CbGeAlD
Ticlopidine—CYP2E1—female reproductive system—skin cancer	0.000156	0.016	CbGeAlD
Ticlopidine—CYP1A1—head—skin cancer	0.000143	0.0146	CbGeAlD
Ticlopidine—CYP2B6—head—skin cancer	0.000139	0.0142	CbGeAlD
Ticlopidine—CYP2E1—head—skin cancer	0.00013	0.0134	CbGeAlD
Ticlopidine—CYP3A4—female reproductive system—skin cancer	0.000125	0.0129	CbGeAlD
Ticlopidine—CYP2D6—female reproductive system—skin cancer	0.000123	0.0127	CbGeAlD
Ticlopidine—CYP2D6—head—skin cancer	0.000103	0.0106	CbGeAlD
Ticlopidine—CYP1A1—lymph node—skin cancer	9.99e-05	0.0103	CbGeAlD
